Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85


Chlamydia trachomatis Oligopeptide Transporter Performs Dual Functions of Oligopeptide Transport and Peptidoglycan Recycling.

Singh R, Liechti G, Slade JA, Maurelli AT.

Infect Immun. 2020 Feb 24. pii: IAI.00086-20. doi: 10.1128/IAI.00086-20. [Epub ahead of print]


Chlamydial MreB Directs Cell Division and Peptidoglycan Synthesis in Escherichia coli in the Absence of FtsZ Activity.

Ranjit DK, Liechti GW, Maurelli AT.

mBio. 2020 Feb 18;11(1). pii: e03222-19. doi: 10.1128/mBio.03222-19.


Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly.

Slade JA, Brockett M, Singh R, Liechti GW, Maurelli AT.

PLoS Pathog. 2019 Oct 17;15(10):e1008078. doi: 10.1371/journal.ppat.1008078. eCollection 2019 Oct.


Distribution and characterization of Shiga toxin converting temperate phages carried by Shigella flexneri in Hispaniola.

Fogolari M, Mavian C, Angeletti S, Salemi M, Lampel KA, Maurelli AT.

Infect Genet Evol. 2018 Nov;65:321-328. doi: 10.1016/j.meegid.2018.07.038. Epub 2018 Jul 31.


Chlamydia trachomatis dapF Encodes a Bifunctional Enzyme Capable of Both d-Glutamate Racemase and Diaminopimelate Epimerase Activities.

Liechti G, Singh R, Rossi PL, Gray MD, Adams NE, Maurelli AT.

mBio. 2018 Apr 3;9(2). pii: e00204-18. doi: 10.1128/mBio.00204-18.


A Brief History of Shigella.

Lampel KA, Formal SB, Maurelli AT.

EcoSal Plus. 2018 Jan;8(1). doi: 10.1128/ecosalplus.ESP-0006-2017. Review.


Investigating the Relatedness of Enteroinvasive Escherichia coli to Other E. coli and Shigella Isolates by Using Comparative Genomics.

Hazen TH, Leonard SR, Lampel KA, Lacher DW, Maurelli AT, Rasko DA.

Infect Immun. 2016 Jul 21;84(8):2362-2371. doi: 10.1128/IAI.00350-16. Print 2016 Aug.


Pathogenic Chlamydia Lack a Classical Sacculus but Synthesize a Narrow, Mid-cell Peptidoglycan Ring, Regulated by MreB, for Cell Division.

Liechti G, Kuru E, Packiam M, Hsu YP, Tekkam S, Hall E, Rittichier JT, VanNieuwenhze M, Brun YV, Maurelli AT.

PLoS Pathog. 2016 May 4;12(5):e1005590. doi: 10.1371/journal.ppat.1005590. eCollection 2016 May.


Evolution of Bacterial Pathogens Within the Human Host.

Bliven KA, Maurelli AT.

Microbiol Spectr. 2016 Feb;4(1). doi: 10.1128/microbiolspec.VMBF-0017-2015. Review.


Stx-Producing Shigella Species From Patients in Haiti: An Emerging Pathogen With the Potential for Global Spread.

Gray MD, Leonard SR, Lacher DW, Lampel KA, Alam MT, Morris JG Jr, Ali A, LaBreck PT, Maurelli AT.

Open Forum Infect Dis. 2015 Sep 19;2(4):ofv134. doi: 10.1093/ofid/ofv134. eCollection 2015 Dec.


Structural characterization of muropeptides from Chlamydia trachomatis peptidoglycan by mass spectrometry resolves "chlamydial anomaly".

Packiam M, Weinrick B, Jacobs WR Jr, Maurelli AT.

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11660-5. doi: 10.1073/pnas.1514026112. Epub 2015 Aug 19.


Chlamydial variants differ in ability to ascend the genital tract in the guinea pig model of chlamydial genital infection.

Yeruva L, Bowlin AK, Spencer N, Maurelli AT, Rank RG.

Infect Immun. 2015 Aug;83(8):3176-83. doi: 10.1128/IAI.00532-15. Epub 2015 May 26.


Phosphoproteomic analysis of the Chlamydia caviae elementary body and reticulate body forms.

Fisher DJ, Adams NE, Maurelli AT.

Microbiology. 2015 Aug;161(8):1648-1658. doi: 10.1099/mic.0.000116. Epub 2015 May 21.


Prevalence of Shiga toxin-producing Shigella species isolated from French travellers returning from the Caribbean: an emerging pathogen with international implications.

Gray MD, Lacher DW, Leonard SR, Abbott J, Zhao S, Lampel KA, Prothery E, Gouali M, Weill FX, Maurelli AT.

Clin Microbiol Infect. 2015 Aug;21(8):765.e9-765.e14. doi: 10.1016/j.cmi.2015.05.006. Epub 2015 May 14.


Clinical isolates of Shiga toxin 1a-producing Shigella flexneri with an epidemiological link to recent travel to Hispañiola.

Gray MD, Lampel KA, Strockbine NA, Fernandez RE, Melton-Celsa AR, Maurelli AT.

Emerg Infect Dis. 2014 Oct;20(10):1669-77. doi: 10.3201/eid2010.140292.


Promiscuous and adaptable enzymes fill "holes" in the tetrahydrofolate pathway in Chlamydia species.

Adams NE, Thiaville JJ, Proestos J, Juárez-Vázquez AL, McCoy AJ, Barona-Gómez F, Iwata-Reuyl D, de Crécy-Lagard V, Maurelli AT.

mBio. 2014 Jul 8;5(4):e01378-14. doi: 10.1128/mBio.01378-14.


Early microRNA expression profile as a prognostic biomarker for the development of pelvic inflammatory disease in a mouse model of chlamydial genital infection.

Yeruva L, Myers GS, Spencer N, Creasy HH, Adams NE, Maurelli AT, McChesney GR, Cleves MA, Ravel J, Bowlin A, Rank RG.

mBio. 2014 Jun 24;5(3):e01241-14. doi: 10.1128/mBio.01241-14. Erratum in: MBio. 2014;5(4):doi: 10.1128/mBio.01575-14.


Potential novel antibiotics from HTS targeting the virulence-regulating transcription factor, VirF, from Shigella flexneri.

Emanuele AA, Adams NE, Chen YC, Maurelli AT, Garcia GA.

J Antibiot (Tokyo). 2014 May;67(5):379-86. doi: 10.1038/ja.2014.10. Epub 2014 Feb 19.


A new metabolic cell-wall labelling method reveals peptidoglycan in Chlamydia trachomatis.

Liechti GW, Kuru E, Hall E, Kalinda A, Brun YV, VanNieuwenhze M, Maurelli AT.

Nature. 2014 Feb 27;506(7489):507-10. doi: 10.1038/nature12892. Epub 2013 Dec 11.


Chlamydia trachomatis transports NAD via the Npt1 ATP/ADP translocase.

Fisher DJ, Fernández RE, Maurelli AT.

J Bacteriol. 2013 Aug;195(15):3381-6. doi: 10.1128/JB.00433-13. Epub 2013 May 24. Erratum in: J Bacteriol. 2014 Jun;196(12):2323.


Antivirulence genes: insights into pathogen evolution through gene loss.

Bliven KA, Maurelli AT.

Infect Immun. 2012 Dec;80(12):4061-70. doi: 10.1128/IAI.00740-12. Epub 2012 Oct 8. Review.


Characterization of the activity and expression of arginine decarboxylase in human and animal Chlamydia pathogens.

Bliven KA, Fisher DJ, Maurelli AT.

FEMS Microbiol Lett. 2012 Dec;337(2):140-6. doi: 10.1111/1574-6968.12021. Epub 2012 Oct 29.


Uptake of biotin by Chlamydia Spp. through the use of a bacterial transporter (BioY) and a host-cell transporter (SMVT).

Fisher DJ, Fernández RE, Adams NE, Maurelli AT.

PLoS One. 2012;7(9):e46052. doi: 10.1371/journal.pone.0046052. Epub 2012 Sep 27.


Effect of inflammatory response on in vivo competition between two chlamydial variants in the guinea pig model of inclusion conjunctivitis.

Rank RG, Bowlin AK, Tormanen KI, Wang Y, Maurelli AT.

Infect Immun. 2012 Feb;80(2):612-9. doi: 10.1128/IAI.06054-11. Epub 2011 Dec 5.


Identification and characterization of the Chlamydia trachomatis L2 S-adenosylmethionine transporter.

Binet R, Fernandez RE, Fisher DJ, Maurelli AT.

mBio. 2011 May 10;2(3):e00051-11. doi: 10.1128/mBio.00051-11. Print 2011.


Chlamydia trachomatis serovar L2 can utilize exogenous lipoic acid through the action of the lipoic acid ligase LplA1.

Ramaswamy AV, Maurelli AT.

J Bacteriol. 2010 Dec;192(23):6172-81. doi: 10.1128/JB.00717-10. Epub 2010 Sep 24.


Microarray analysis of Shigella flexneri-infected epithelial cells identifies host factors important for apoptosis inhibition.

Faherty CS, Merrell DS, Semino-Mora C, Dubois A, Ramaswamy AV, Maurelli AT.

BMC Genomics. 2010 Apr 29;11:272. doi: 10.1186/1471-2164-11-272.


Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs.

Binet R, Bowlin AK, Maurelli AT, Rank RG.

Antimicrob Agents Chemother. 2010 Mar;54(3):1094-101. doi: 10.1128/AAC.01321-09. Epub 2010 Jan 11.


Spa15 of Shigella flexneri is secreted through the type III secretion system and prevents staurosporine-induced apoptosis.

Faherty CS, Maurelli AT.

Infect Immun. 2009 Dec;77(12):5281-90. doi: 10.1128/IAI.00800-09. Epub 2009 Oct 5.


Transformation and isolation of allelic exchange mutants of Chlamydia psittaci using recombinant DNA introduced by electroporation.

Binet R, Maurelli AT.

Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):292-7. doi: 10.1073/pnas.0806768106. Epub 2008 Dec 22.


Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein.

Zurawski DV, Mumy KL, Faherty CS, McCormick BA, Maurelli AT.

Mol Microbiol. 2009 Jan;71(2):350-68. doi: 10.1111/j.1365-2958.2008.06524.x. Epub 2008 Nov 14.


Staying alive: bacterial inhibition of apoptosis during infection.

Faherty CS, Maurelli AT.

Trends Microbiol. 2008 Apr;16(4):173-80. doi: 10.1016/j.tim.2008.02.001. Epub 2008 Mar 18. Review.


nadA and nadB of Shigella flexneri 5a are antivirulence loci responsible for the synthesis of quinolinate, a small molecule inhibitor of Shigella pathogenicity.

Prunier AL, Schuch R, Fernández RE, Mumy KL, Kohler H, McCormick BA, Maurelli AT.

Microbiology. 2007 Jul;153(Pt 7):2363-2372. doi: 10.1099/mic.0.2007/006916-0.


Genetic structure of the nadA and nadB antivirulence loci in Shigella spp.

Prunier AL, Schuch R, Fernández RE, Maurelli AT.

J Bacteriol. 2007 Sep;189(17):6482-6. Epub 2007 Jun 22.


Shigella flexneri inhibits staurosporine-induced apoptosis in epithelial cells.

Clark CS, Maurelli AT.

Infect Immun. 2007 May;75(5):2531-9. Epub 2007 Mar 5.


L,L-diaminopimelate aminotransferase, a trans-kingdom enzyme shared by Chlamydia and plants for synthesis of diaminopimelate/lysine.

McCoy AJ, Adams NE, Hudson AO, Gilvarg C, Leustek T, Maurelli AT.

Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17909-14. Epub 2006 Nov 8.


OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence.

Zurawski DV, Mitsuhata C, Mumy KL, McCormick BA, Maurelli AT.

Infect Immun. 2006 Oct;74(10):5964-76.


Building the invisible wall: updating the chlamydial peptidoglycan anomaly.

McCoy AJ, Maurelli AT.

Trends Microbiol. 2006 Feb;14(2):70-7. Epub 2006 Jan 18. Review.


Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp.

Binet R, Maurelli AT.

Antimicrob Agents Chemother. 2005 Jul;49(7):2865-73.


Structure and biochemical analysis of a secretin pilot protein.

Lario PI, Pfuetzner RA, Frey EA, Creagh L, Haynes C, Maurelli AT, Strynadka NC.

EMBO J. 2005 Mar 23;24(6):1111-21. Epub 2005 Mar 10.


A DNA adenine methylase mutant of Shigella flexneri shows no significant attenuation of virulence.

Honma Y, Fernández RE, Maurelli AT.

Microbiology. 2004 Apr;150(Pt 4):1073-1078. doi: 10.1099/mic.0.26781-0.


Inhibition of Salmonella typhimurium enteropathogenicity by piperidine, a metabolite of the polyamine cadaverine.

Köhler H, Rodrigues SP, Maurelli AT, McCormick BA.

J Infect Dis. 2002 Oct 15;186(8):1122-30. Epub 2002 Sep 20.


Supplemental Content

Loading ...
Support Center